Environmental Impact Report Approved for Langhua Pharma

We have recently received environmental approvals to expand production capacity of peptides and advanced intermediates for other small-molecule drugs. As part of the approved plan, we will remodel three existing plants.

This expansion will further advance our production capabilities and capacities, enabling us to deliver scalable and reliable CDMO solutions to leading global pharmaceutical partners.